Home/NewAmsterdam Pharma/B.J. Jones

BJ

B.J. Jones

Chief Commercial Officer

NewAmsterdam Pharma

Roles

Chief Commercial OfficeratNewAmsterdam Pharma

Chief Commercial OfficeratNewAmsterdam Pharma Company

Therapeutic Areas

Cardiovascular Disease Dyslipidemia Alzheimer's Disease

NewAmsterdam Pharma Pipeline

Drug	Indication	Phase
Obicetrapib Monotherapy	Heterozygous Familial Hypercholesterolemia (HeFH)	Phase 3
Obicetrapib + Ezetimibe (FDC)	HeFH and/or ASCVD	Phase 3
Obicetrapib	Cardiovascular Outcomes	Phase 3

Leadership Team at NewAmsterdam Pharma

Dr. Michael Davidson

Co-founding Chief Executive Officer

Professor Dr. John Kastelein

Co-founder and Chief Scientific Officer

View full NewAmsterdam Pharma profile